Procter & Gamble Hygiene & Health Care Ltd. Stock Hits 52-Week Low at Rs.11002

Stock Price Movement and Market Context

On 2 March 2026, Procter & Gamble Hygiene & Health Care Ltd. (Stock ID: 927063) opened sharply lower with a gap down of -3.1%, touching an intraday low of Rs.11002, which represents its lowest level in the past year. The stock has been on a downward trend for the last two consecutive days, losing -1.89% over this period. Despite this, it marginally outperformed its sector by 0.54% on the day.

The stock currently trades below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish momentum. This contrasts with the broader market, where the Sensex, after a steep gap down of 2,743.46 points, recovered by 1,269.14 points to trade at 79,812.87, down -1.81% on the day. The Sensex remains below its 50-day moving average, though the 50DMA is positioned above the 200DMA, indicating mixed technical signals for the benchmark.

Long-Term Performance and Valuation Metrics

Over the past year, Procter & Gamble Hygiene & Health Care Ltd. has delivered a total return of -16.69%, underperforming the Sensex, which gained 9.04% during the same period. The stock’s 52-week high was Rs.14,536.60, highlighting the extent of the recent decline.

Financially, the company has exhibited modest growth with net sales increasing at an annualised rate of 5.52% and operating profit growing at 5.34% over the last five years. Despite this, the stock’s valuation remains elevated, with a price-to-book value of 39.2 and a return on equity (ROE) of 92.3, indicating a very expensive valuation relative to its book value. The PEG ratio stands at 2.1, reflecting the relationship between price, earnings growth, and valuation.

Comparative Performance and Market Position

The stock has consistently underperformed its benchmark indices over the last three years, including the BSE500, reflecting challenges in maintaining competitive returns. While profits have risen by 20.1% over the past year, this has not translated into positive stock price performance, underscoring a disconnect between earnings growth and market valuation.

Procter & Gamble Hygiene & Health Care Ltd. holds a Mojo Score of 43.0 and was downgraded from a Hold to a Sell rating on 17 October 2024. Its Market Cap Grade is 2, indicating a mid-cap status with moderate market capitalisation relative to peers.

Financial Strength and Operational Highlights

The company demonstrates strong management efficiency, with a high ROE of 81.87%, and maintains a low average debt-to-equity ratio of zero, reflecting a debt-free capital structure. Recent quarterly results for December 2025 showed net sales at a record Rs.1,261.90 crores and PBDIT reaching Rs.401.80 crores, the highest recorded in recent periods. The operating profit margin to net sales also peaked at 31.84%, indicating operational profitability at a strong level.

Shareholding and Sectoral Context

The majority shareholding remains with the promoters, providing stability in ownership. Operating within the FMCG sector, the company faces competitive pressures and valuation scrutiny, especially given its premium price-to-book ratio compared to peers. The sector itself has shown resilience, but Procter & Gamble Hygiene & Health Care Ltd.’s stock price has not mirrored this trend, reflecting specific valuation and performance concerns.

Summary of Key Metrics

To summarise, the stock’s 52-week low of Rs.11002 is a reflection of its recent price weakness amid a recovering market. The company’s financials show steady sales and profit growth, but elevated valuation multiples and underperformance relative to benchmarks have weighed on investor sentiment. Trading below all major moving averages and with a recent downgrade to a Sell rating, the stock’s current position highlights the challenges it faces in regaining upward momentum.

Technical and Market Indicators

Technical indicators reinforce the bearish stance, with the stock trading below its short, medium, and long-term moving averages. The gap down opening and intraday low of Rs.11002 underline the selling pressure. Meanwhile, the Sensex’s partial recovery after a sharp fall suggests broader market volatility, contrasting with the stock’s continued decline.

Conclusion

Procter & Gamble Hygiene & Health Care Ltd.’s new 52-week low marks a notable point in its price trajectory, reflecting a combination of valuation concerns, relative underperformance, and technical weakness. While the company maintains strong operational metrics and a solid balance sheet, the stock’s market performance remains subdued in comparison to sector peers and benchmark indices.

Limited Period Only. Start at Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Get 71% Off →